Uncertainty over Skyclarys decision as HSE team to meet
The HSE Senior Leadership Team will meet to discuss the drug Skyclarys, which is for people with the rare neurological condition, Friedreich's ataxia.
We haven't written up this one. RTE News has the full story — the link below goes straight to it.